The Claim
Computational analysis indicates that aspartame exposure is associated with molecular alterations in kidney renal papillary cell carcinoma involving extracellular matrix remodeling, immune regulation, and metabolic disruption, based on overlapping gene targets between aspartame and KIRP.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Computational models suggest that aspartame may interact with biological pathways related to kidney cancer, including changes in the extracellular matrix, immune function, and metabolism, through shared gene targets.
See the scientific wording
Computational analysis suggests aspartame may influence kidney renal papillary cell carcinoma through mechanisms involving extracellular matrix remodeling, immune regulation, and metabolic disruption, based on overlapping gene targets between aspartame and KIRP, though no direct evidence of aspartame exposure in patients was assessed.
Aspartame binds to key proteins in kidney cells, blocking detoxification, triggering abnormal cell growth, damaging DNA, and altering tissue structure and immune signals, which together cause cancer cells to multiply and spread.
What the research says
1 studyComputer models found that aspartame might interact with genes in the kidney that are also involved in a rare type of kidney cancer, affecting tissue structure, immune response, and metabolism — suggesting a possible link, even though they didn’t measure how much aspartame people ate.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.